CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael David, MD
Rabin Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Centre of Republika Srpska
Banja Luka, Bosnia and Herzegovina
- University Clinical Centre Mostar
Mostar, Bosnia and Herzegovina
- Clinical Centre of Sarajevo University
Sarajevo, Bosnia and Herzegovina
- "multiprofile Hospital for Active Treatment - Pazardzhik"
Pazardzhik, Bulgaria
- "mhat"rahila Angelova"ad, Department of Skin and Venereal Diseases
Pernik, Bulgaria
- "university Multiprofile Hospital for Active Treatment - D-R Georgi Stranski" - Ead, Pleven, Clinic of Skin and Venereal Diseases
Pleven, Bulgaria
- "diagnostic-Consultative Aleksandrovska" Eood
Sofia, Bulgaria
- "diagnostic-Consultative Centre Xx - Sofia" Eood
Sofia, Bulgaria
- Ambulatory for Specialized Medical Help - Group Practice Dermatology - Clinic Euroderma" Ood
Sofia, Bulgaria
- K. Papp Clinical Research
Waterloo, Canada
- Clinical Hospital Center Rijeka
Rijeka, Croatia
- Sestre Milosrdnice University Hospital Center
Zagreb, Croatia
- Rambam Medical Center
Haifa, Israel
- Institutul de Cardiologie
Chisinau, Moldova
- Spitalul Clinic Municipal Nr. 3 "sfanta Treime"
Chisinau, Moldova
- Spitalul Clinic Republican
Chisinau, Moldova
- Centrum Usług Medycznych Maxmed
Bochnia, Poland
- Gdańskim Centrum Zdrowia
Gdansk, Poland
- All-Med Centrum Medyczne
Lodz, Poland
- Miejski Szpital Zespolony Klinika Dermatologii Chorób Przenoszonych Drogą Płciową I Immunologii Klinicznej
Olsztyn, Poland
- Etg Zamość, Ul. Szczebrzeska 11i
Zamość, Poland
- Lubelskie Centrum Diagnostyczne
Świdnik, Poland
- Centrul Medical de Diagnostic Si Tratament Ambulator Neomed Srl
Brasov, Romania
- Sc Pelican Impex Srl
Oradea, Romania
- Spitalul Clinic Județean de Urgență Sibiu
Sibiu, Romania
- Clinical Centre of Serbia
Belgrade, Serbia
- Clinical Centre Nis
Niš, Serbia
- Military Hospital Nis
Niš, Serbia
- General Hospital Sremska Mitrovica
Sremska Mitrovica, Serbia
- General Hospital Zajecar
Zaječar, Serbia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Sept 2018
- Primary completion
- 6 Jan 2022
- Completion
- 27 Apr 2022
- Last update posted
- 28 Jun 2022
- Registered enrollment
- 528
- Registry id
- NCT03168256
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.